|
|
 |
|
Viewing report
|
|
|
|
The Pharmaceutical Market: Cuba
Espicom Business Intelligence Ltd, Feb 2008, Pages: 96
Cuba is one of the world's last unreconstructed communist countries. Under Dr Fidel Castro’s Presidency, Cuba has attempted none of the economic reforms implemented in Eastern Europe or even China. With his brother Raul taking over the Presidency in February 2008 and with Fidel still acting as consultant to major decisions, it appears that political changes will be slow, if they happen. Despite this, the country has a reputation for the quality of its health services and health indicators, and has an impressive pharmaceutical/biotechnology research sector. This reputation is deserved in part, but conceals an ageing healthcare system in dire need of restructuring and modernising, none of which can be achieved without greatly increased funding.
During the Cold War, Cuba was a major Soviet ally, and the market remained largely closed to the West. During the 1990s, however, many countries in the West established links with Cuba. The USA, virtually alone, maintains its embargo against Cuba. This is starting to hurt US healthcare firms, as companies based in Asia, Canada and Western Europe have the high-tech market to themselves. The international healthcare industry is taking an increasing interest in Cuba, which in turn has made efforts to integrate into the global marketplace in an attempt to attract new funding for its healthcare system.
Since its realignment under the consortium QUIMEFA in 2001, domestic pharmaceutical production has kept growing, with increasing biotechnology export opportunities not only in developing countries but also in Europe and other developed countries. Cuba maintains a list of essential medicines (CBM – Cuadro Basico de Medicamentos), which contained 828 medicines in 2007, of which 525 are domestically produced. There is no commercial advertising in Cuba, instead advertising has an educational purpose. Cuba affords some level of pharmaceutical patent protection, although less than international norms. Since 2001, FARMACUBA has acted as importer, exporter and distributor for QUIMEFA.
Customers who bought this item also bought
The Medical Device Market: Cuba
Cuba - Telecoms, Mobile and Broadband
Cuba - Telecoms Mobile and Broadband
Executive Report on Strategies in Cuba
The 2009 Cuba Economic and Product Market Databook
The 2006 Cuba Economic and Product Market Databook
Cuba Energy Market Profile: Covers Detailed Analysis of Oil, Gas, Coal and Electricity Sectors
The 2009 Economic and Product Market Databook for Santiago de Cuba, Cuba
The Economic Competitiveness of Cuba: Financials Returns, Labor Productivity and International Gaps
Life Sciences Funding in Europe (2007)
The 2009 Economic and Product Market Databook for Bayamo, Cuba
The 2009 Economic and Product Market Databook for Camag�ey, Cuba
|
|
|
|
